BioSpace News Archive

With the addition of GlycOCATCH, Genovis is expanding its already unique offering of products within the field of O-glycans and streangthens its position as an innovator in this market.

Moleculin Biotech, Inc., announced that Dr. Waldemar Priebe, Chair of the Company’s Scientific Advisory Board, has been selected to present findings on Moleculin’s STAT3 inhibitor and immuno-stimulating agent, WP1066, at the Global Academic Programs 2018 in Stockholm, Sweden in May of this year.

Context Therapeutics, LLC, announced that Martin Lehr, Co-founder and CEO of Context Therapeutics, is a semifinalist for Ernst & Young’s (EY) 2018 Entrepreneur of the Year for the Greater Philadelphia region.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced five poster presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting being held June 1-5, 2018 in Chicago, Illinois.

Navitus Health Solutions today announced its Residency Program Director, Marleen (Marnie) Wickizer, was named winner of the 2018 Association of Managed Care Pharmacy (AMCP) Award for Managed Care Pharmacy Residency Director/Preceptor.

Comprehensive Database of 500,000+ Clinical Phenotype Records Supports Ocular Disease Research

Researchers are increasingly choosing Quanterix’ ultra-sensitive technology to power advancements in neurology

Proniras Corporation announced that it has been awarded a contract potentially worth $89.5 million from the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA) to develop tezampanel as a medical countermeasure for the treatment of nerve agent-induced seizures that are not stopped by current medications.

Essity announced that it will expand its partnership with Silicon Valley’s Plug and Play.